Marek Svoboda
- Molecular Biology top 2%
- Cancer Research top 0.2%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Surgery top 10%
- Co-authors
- Ondřej SlabýRostislav VyzulaPavel FabiánLenka RadováJiří ŠáňaAlexandr PoprachPetra FaltejskováRadek Lakomý
- Topics
- MicroRNA in disease regulation (46 papers)Cancer-related molecular mechanisms research (44 papers)Circular RNAs in diseases (33 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- CzechiaAustriaUnited States
In The Last Decade
Marek Svoboda
131 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Molecular Biology 3.9k
- Cancer Research 3.6k
- Oncology 769
- Pulmonary and Respiratory Medicine 644
- Surgery 365
Countries citing papers authored by Marek Svoboda
This map shows the geographic impact of Marek Svoboda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Svoboda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Svoboda more than expected).
Fields of papers citing papers by Marek Svoboda
This network shows the impact of papers produced by Marek Svoboda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Svoboda. The network helps show where Marek Svoboda may publish in the future.
Co-authorship network of co-authors of Marek Svoboda
This figure shows the co-authorship network connecting the top 25 collaborators of Marek Svoboda. A scholar is included among the top collaborators of Marek Svoboda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marek Svoboda. Marek Svoboda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 8 | |
| 6 | 5 | |
| 7 | 8 | |
| 8 | 9 | |
| 9 | 61 | |
| 10 | Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapy | 2 |
| 11 | 15 | |
| 12 | 15 | |
| 13 | 10 | |
| 14 | 38 | |
| 15 | 52 | |
| 16 | 19 | |
| 17 | Výsledky multimodální léčby glioblastoma multiforme:konsekutivní série 86 pacientů diagnostikovaných v letech2003–2009 | 1 |
| 18 | Significance of microRNA-21 in colorectal cancer pathogenesis. | 1 |
| 19 | Brain metastases in breast cancer: a retrospective cohort studyof 187 patients and prognostic markers determination. | 1 |
| 20 | Statiny v onkologii | 1 |
About Marek Svoboda
Marek Svoboda is a scholar working on Cancer Research, Oncology and Chemical Health and Safety, having authored 139 papers that have together received 5.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (46 papers), Cancer-related molecular mechanisms research (44 papers) and Circular RNAs in diseases (33 papers). The work is most often cited by research in Cancer Research (3.6k citations), Molecular Biology (3.9k citations) and Oncology (769 citations). Marek Svoboda has collaborated with scholars based in Czechia, Austria and United States. Frequent co-authors include Ondřej Slabý, Rostislav Vyzula, Pavel Fabián, Lenka Radová, Jiří Šáňa, Alexandr Poprach, Petra Faltejsková, Radek Lakomý, Jaroslav Michálek and Rudolf Nenutil. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.